Cantargia AB (publ)
STO: CANTA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hilde Hermansen Steineger
- Employees
- 22
- Headquarters
- Lund, Sweden
- IPO year
- 2015
- Market cap
- SEK 865.2M
- Website
- https://www.cantargia.com
Loading CANTA…
Loading profile data…Frequently asked questions about CANTA
What does Cantargia AB (publ) (CANTA.ST) do?
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as bl...
Where does CANTA.ST trade?
Cantargia AB (publ) (CANTA.ST) trades on the Stockholm Stock Exchange.
What sector is CANTA.ST in?
Cantargia AB (publ) (CANTA.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cantargia AB (publ)?
Hilde Hermansen Steineger is the chief executive officer of Cantargia AB (publ) (CANTA.ST).
Where is Cantargia AB (publ) headquartered?
Cantargia AB (publ) is headquartered in Sweden.
Does CANTA.ST pay a dividend?
Cantargia AB (publ) (CANTA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CANTA.ST go public?
Cantargia AB (publ) (CANTA.ST) completed its initial public offering in 2015.